Thus, most natural proteins administered as therapeutics to patients have suboptimal properties for treating the target disease. Natural proteins are not only less efficacious and less safe than ...

As demand surges for sustainable and bio-based active pharmaceutical ingredients, manufacturers are investing in advanced extraction technologies and green chemistry to meet the rising need for safer, ...

Natural IgMs are potential therapeutics. Clinical trials to treat multiple sclerosis with human natural IgM are underway.

Gene editing firm CRISPR Therapeutics has announced a collaboration with US biotech Nkarta to develop natural killer (NK) cell therapies for cancer. This latest agreement follows a major deal with ...